FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

4628011000001105: Dapsone 100mg / Pyrimethamine 12.5mg tablets 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21289701000001117 Dapsone 100mg / Pyrimethamine 12.5mg tablets 30 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21289801000001114 Dapsone 100mg / Pyrimethamine 12.5mg tablets 30 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dapsone 100mg / Pyrimethamine 12.5mg tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Dapsone 100mg / Pyrimethamine 12.5mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Dapsone 100mg / Pyrimethamine 12.5mg tablets 30 tablet Is pack of Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Dapsone 100mg / Pyrimethamine 12.5mg tablets 30 tablet Has active ingredient Pyrimethamine false Inferred relationship Existential restriction modifier
Dapsone 100mg / Pyrimethamine 12.5mg tablets 30 tablet Has active ingredient Dapsone false Inferred relationship Existential restriction modifier
Dapsone 100mg / Pyrimethamine 12.5mg tablets 30 tablet VMP prescribing status (attribute) VMP invalid as a prescribable product true Inferred relationship Existential restriction modifier
Dapsone 100mg / Pyrimethamine 12.5mg tablets 30 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Dapsone 100mg / Pyrimethamine 12.5mg tablets 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Dapsone 100mg / Pyrimethamine 12.5mg tablets 30 tablet Has VMP Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Dapsone 100mg / Pyrimethamine 12.5mg tablets 30 tablet Has specific active ingredient Dapsone true Inferred relationship Existential restriction modifier
Dapsone 100mg / Pyrimethamine 12.5mg tablets 30 tablet Has specific active ingredient Pyrimethamine true Inferred relationship Existential restriction modifier
Dapsone 100mg / Pyrimethamine 12.5mg tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Maloprim tablets (GlaxoSmithKline) 30 tablet Is a True Dapsone 100mg / Pyrimethamine 12.5mg tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start